Brief: Oncolytics Biotech Reports Preclinical Data Demonstrating Synergistic Anti-Cancer Activity Of Pelareorep Combined With Car T Cell Therapy In Solid Tumors

Oncolytics Biotech

23/02/2021 12:23

Feb 23 (Reuters) - Oncolytics Biotech Inc  ONC.TO :
    * ONCOLYTICS BIOTECH REPORTS PRECLINICAL DATA DEMONSTRATING
SYNERGISTIC ANTI-CANCER ACTIVITY OF PELAREOREP COMBINED WITH CAR
T CELL THERAPY IN SOLID TUMORS
    * ONCOLYTICS BIOTECH INC - MAYO CLINIC SHOWS PELAREOREP
VASTLY
IMPROVED PERSISTENCE AND EFFICACY OF CAR T CELL THERAPY LEADING
TO CURES IN MODEL
    * ONCOLYTICS BIOTECH INC - PELAREOREP'S SYNERGISTIC EFFECTS
WITH
CAR T THERAPY APPEAR TO BE SPECIFIC AND WERE NOT OBSERVED WITH
ONCOLYTIC VIRUS VSV
    * ONCOLYTICS BIOTECH INC - RESULTS DEMONSTRATE POTENTIAL OF
PELAREOREP TO BROADEN APPLICABILITY OF CAR T CELLS TO SOLID
TUMORS

Source text for Eikon:  ID:nCNWG1VRda 
Further company coverage:  ONC.TO 

 ((Reuters.Briefs@thomsonreuters.com;))